Morgan Cheatham is a vice president in the New York City office where he focuses on investments in healthcare and life sciences from early to growth stages. He has a particular interest in companies leveraging unique datasets and computational methods to improve patient care from bench to bedside. Morgan works closely with a number of portfolio companies including serving on the board of FOLX Health.
Before joining Bessemer, Morgan worked at Goldman Sachs in the Consumer Retail and Healthcare Group in the Investment Banking Division. Prior to investment banking, he was a data scientist at Kyruus, a healthcare IT startup focused on patient access and provider data management.
Morgan is pursuing his medical degree at The Warren Alpert Medical School of Brown University and graduated magna cum laude from Brown University with a B.S. in neuroeconomics. You can follow his latest thinking on Twitter @morgancheatham.
Abridge records the details of your care and helps you stay on top of your health, one conversation at a time.
Hinge Health pioneers the world's most patient-centered digital hospital, starting with musculoskeletal health.
productboard is the product management system that helps organizations get the right products to market, faster.
Qventus optimizes decisions in hospitals in real time to reduce costs, improve quality and experience.
Subtle Medical uses AI to redefine the standards for medical imaging, making it faster, safer, and smarter.
Watershed is a verticalized Bio-IT cloud data lab technology that finds bioinformatics tools for biologists, helping biologists and bioinformaticians with assistance for more efficient and effective experimentation.
Turquoise Health is a healthcare information services company that reduces the cost and complexity of healthcare by simplifying administration.
